HIV patients taking a combination of two protease inhibitors
December 1997
You'll see more HIV patients taking a combination of two protease inhibitors...instead of the usual triple therapy.
The most common protease inhibitor combo is ritonavir (Norvir) plus saquinavir. This combo makes sense. Ritonavir inhibits the metabolism of saquinavir...increasing saquinavir levels 17-fold.
This results in better viral suppression...comparable to the usual triple drug regimens.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote